Literature DB >> 21934101

Sclerosing cholangitis in baboons (Papio spp) resembling primary sclerosing cholangitis of humans.

A M Arenas-Gamboa1, J J Bearss, G B Hubbard, B F Porter, M A Owston, E J Dick.   

Abstract

Primary sclerosing cholangitis is a chronic and progressive cholestatic liver disease that has been extensively documented in the human literature. Although it shares many features in common with chronic lymphocytic cholangitis in cats, primary sclerosing cholangitis has never been reported in a nonhuman primate. Primary sclerosing cholangitis is characterized by the presence of intrahepatic and/or extrahepatic inflammation and concentric fibrosis of bile ducts, eventually leading to cirrhosis and hepatic failure. The pathogenesis and cause remain unknown, but the disease likely involves a multifactorial mechanism with genetic- and immune-mediated components. The authors report 2 cases that histologically resemble the condition in humans; they consist of 2 adult male baboons with a clinical history of chronic elevated liver enzymes. In both cases, the liver was histologically characterized by thick bands of fibrosis and mild lymphoplasmacytic periportal cholangiohepatitis with concentric periductal fibrosis, resulting in atrophy and loss of bile ducts. Immunohistochemical analysis revealed positivity of hepatocytes to cytokeratin 7. Masson stain demonstrated marked biliary fibrosis. This is the first report that resembles sclerosing cholangitis in a nonhuman primate, and it suggests that the baboon may provide a useful animal model for this condition in humans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934101      PMCID: PMC4442673          DOI: 10.1177/0300985811419532

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  17 in total

1.  Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.

Authors:  K Wiencke; T H Karlsen; K M Boberg; E Thorsby; E Schrumpf; B A Lie; A Spurkland
Journal:  Tissue Antigens       Date:  2007-02

Review 2.  Etiopathogenesis of primary sclerosing cholangitis.

Authors:  Roger Chapman; Sue Cullen
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

3.  Genome-wide association analysis in primary sclerosing cholangitis.

Authors:  Tom H Karlsen; Andre Franke; Espen Melum; Arthur Kaser; Johannes Roksund Hov; Tobias Balschun; Benedicte A Lie; Annika Bergquist; Christoph Schramm; Tobias J Weismüller; Daniel Gotthardt; Christian Rust; Eva E R Philipp; Teresa Fritz; Liesbet Henckaerts; Rinse K Weersma; Pieter Stokkers; Cyriel Y Ponsioen; Cisca Wijmenga; Martina Sterneck; Michael Nothnagel; Jochen Hampe; Andreas Teufel; Heiko Runz; Philip Rosenstiel; Adolf Stiehl; Severine Vermeire; Ulrich Beuers; Michael P Manns; Erik Schrumpf; Kirsten Muri Boberg; Stefan Schreiber
Journal:  Gastroenterology       Date:  2009-11-26       Impact factor: 22.682

Review 4.  Update on primary sclerosing cholangitis.

Authors:  Tom H Karlsen; Erik Schrumpf; Kirsten M Boberg
Journal:  Dig Liver Dis       Date:  2010-02-20       Impact factor: 4.088

5.  [Primary sclerosing cholangitis].

Authors:  N F LaRusso; J Ludwig
Journal:  Dtsch Med Wochenschr       Date:  1986-08-15       Impact factor: 0.628

6.  CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.

Authors:  Martin Wagner; Emina Halilbasic; Hanns-Ulrich Marschall; Gernot Zollner; Peter Fickert; Cord Langner; Kurt Zatloukal; Helmut Denk; Michael Trauner
Journal:  Hepatology       Date:  2005-08       Impact factor: 17.425

7.  Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis.

Authors:  J Ludwig; R L MacCarty; N F LaRusso; R A Krom; R H Wiesner
Journal:  Hepatology       Date:  1986 Jul-Aug       Impact factor: 17.425

8.  Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.

Authors:  Annika Bergquist; Scott M Montgomery; Shahram Bahmanyar; Rolf Olsson; Ake Danielsson; Stefan Lindgren; Hanne Prytz; Rolf Hultcrantz; L A R S Lööf; Hanna Sandberg-Gertzén; Sven Almer; Johan Askling; Anna Ehlin; Anders Ekbom
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08       Impact factor: 11.382

9.  Chronic lymphocytic cholangitis in three cats.

Authors:  K W Prasse; E A Mahaffey; R DeNovo; L Cornelius
Journal:  Vet Pathol       Date:  1982-03       Impact factor: 2.221

Review 10.  The immunobiology of primary sclerosing cholangitis.

Authors:  Jonathan H Aron; Christopher L Bowlus
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

View more
  2 in total

Review 1.  Characterization of animal models for primary sclerosing cholangitis (PSC).

Authors:  Peter Fickert; Marion J Pollheimer; Ulrich Beuers; Carolin Lackner; Gideon Hirschfield; Chantal Housset; Verena Keitel; Christoph Schramm; Hanns-Ulrich Marschall; Tom H Karlsen; Espen Melum; Arthur Kaser; Bertus Eksteen; Mario Strazzabosco; Michael Manns; Michael Trauner
Journal:  J Hepatol       Date:  2014-02-19       Impact factor: 25.083

Review 2.  Animal models in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Marion J Pollheimer; Peter Fickert
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.